Trial intelligence / Profile preview

Systemic effects of mild renal insufficiency: relation between forearm blood flow and ADMA

2007-005546-20Phase 4Active

Sponsor
Maastricht University Medical Center+
Start
Oct 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of rosuvastatin and olmesartan in hypertension (HTN) and chronic kidney disease (CKD), sponsored by Maastricht University Medical Center+. Primary endpoint: Forearm blood flow. Started Oct 2007; status: active.

02

Drugs

rosuvastatinolmesartan
03

Conditions

hypertension (HTN)chronic kidney disease (CKD)

Beyond the preview

Go deeper on 2007-005546-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005546-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call